Role of Wnt/β-Catenin Signalling in Acute Myeloid Leukemia (AML) Cell Response to Chemotherapy

被引：0
|
作者：
Kamga, Paul Takam [1 ]
Cassaro, Adriana [1 ]
Dal Collo, Giada [1 ]
Adamo, Annalisa [1 ]
Gatti, Alessandro [1 ]
Carusone, Roberta [1 ]
Midolo, Martina [1 ]
Di Trapani, Mariano [1 ]
Resci, Federica [1 ]
Bonifacio, Massimiliano [1 ]
Krampera, Mauro [1 ]
机构：
[1] Univ Verona, Sect Hematol, Dept Med, Stem Cell Res Lab, Verona, Italy
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2753
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Trends in chemotherapy utilization in acute myeloid leukemia (AML) in last 15 years
    Dhakal, Prajwal
    Loeffler, Bradley
    Ravindra, Aditya
    Pyakuryal, Avantika
    Bhatt, Vijaya Raj
    CANCER RESEARCH, 2024, 84 (06)
  • [32] INTENSIVE POSTREMISSION CONSOLIDATION CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA (AML) IN ADULTS
    BERNASCONI, C
    LAZZARINO, M
    MORRA, E
    CANEVARI, A
    CASTELLI, G
    BRUSAMOLINO, E
    ALESSANDRINO, EP
    PAGNUCCO, G
    ORLANDI, E
    INVERARDI, D
    CASTAGNOLA, C
    LEUKEMIA RESEARCH, 1986, 10 (01) : 108 - 108
  • [33] Chemotherapy as Treatment for Acute Myeloid Leukemia (AML)-Induced Facial Nerve Palsy
    Fana, Michael
    Centofanti, Brook
    Kuriakose, Philip
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (03)
  • [34] Cost impact of filgrastim as an adjunct to chemotherapy for patients with acute myeloid leukemia (AML).
    Lu, ZJ
    Shi, J
    Erder, MH
    Heil, G
    Ganser, A
    Lechner, K
    Yin, JL
    Szer, J
    Barge, A
    BLOOD, 1997, 90 (10) : 314 - 314
  • [35] β-catenin mutations in acute myeloid leukemia
    Gunes, Buket A.
    Ozkan, Tulin
    Gurel, Aynur K.
    Hekmatshoar, Yalda
    Beksac, Meral
    Sunguroglu, Asuman
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2020, 45 (02): : 105 - 110
  • [36] Mathematical models to identify combined protein and clinical biomarkers of response to induction chemotherapy in acute myeloid leukemia (AML)
    Tibes, Raoul
    Meurice, Natalie
    Anthony, Steven P.
    Qiu, YiHua
    Komblau, Steven M.
    Mousses, Spyro
    Petit, Joachim
    BLOOD, 2007, 110 (11) : 708A - 708A
  • [37] Acute Myeloid Leukemia (AML) from Older HSCs Is Resistant to Chemotherapy and Has an Altered DNA Damage Response
    Pladna, Kristin
    Pardee, Timothy
    BLOOD, 2023, 142
  • [38] Is It Time to Redefine Response in Elderly Patients with WHO-Acute Myeloid Leukemia (AML) Unfit for Intensive Chemotherapy?
    Pleyer, Lisa
    Burgstaller, Sonja
    Stauder, Reinhard
    Girschikofsky, Michael
    Sill, Heinz
    Schlick, Konstantin
    Thaler, Josef
    Halter, Britta
    Machherndl-Spandl, Sigrid
    Zebisch, Armin
    Pichler, Angelika
    Pfeilstoecker, Michael
    Autzinger, Eva-Maria
    Lang, Alois
    Geissler, Klaus
    Voskova, Daniela
    Geissler, Diermar
    Sperr, Wolfgang R.
    Hojas, Sabine
    Rogulj, Inga Mandac
    Andel, Johannes
    Greil, Richard
    BLOOD, 2015, 126 (23)
  • [39] Combination of Dasatinib with Conventional Chemotherapy Is Associated with a High Response Rate in High Risk Acute Myeloid Leukemia (AML)
    Aribi, Ahmed
    Dos Santos, Cedric
    O'Donnell, Margaret
    Stein, Anthony S.
    Lin, Allen
    Palmer, Joycelynne M.
    Zhuo, Meng
    Snyder, David
    Ali, Haris
    Chen, Robert
    Popplewell, Leslie L.
    Nathwani, Nitya
    Khaled, Samer K.
    Salhotra, Amandeep
    Herrera, Alex
    Aldoss, Ibrahim
    Smith, Eileen P.
    Marcucci, Guido
    Forman, Stephen J.
    Bhatia, Ravi
    BLOOD, 2015, 126 (23)
  • [40] Acute Myeloid Leukemia and the Wnt Pathway
    Eaves, Connie J.
    Humphries, R. Keith
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (24): : 2326 - 2327
12345